Hyeoung‐Joon Kim

14 ta ish

Chonnam National University Hwasun Hospital

1. Expanded natural killer cells augment the antimyeloma effect of daratumumab, bortezomib, and dexamethasone in a mouse model

   Jaya Lakshmi Thangaraj, Seo-Yeon Ahn, Sung‐Hoon Jung +12

   MaqolaOAOchiq kirish20213 iqtibos

   ABIABI:AkademIndex/2026.other.102891

2. Anti-BCMA Dual Epitope-Binding CAR-Marrow Infiltrating Lymphocytes (MILs) Could Offer a Potent Innovative Immunotherapeutic Tool Against Multiple Myeloma

   Manh-Cuong Vo, Sunghoon Jung, Van‐Tan Nguyen +6

   Maqola20232 iqtibos

   ABIABI:AkademIndex/2026.other.102952

3. Lenalidomide Synergistically Enhances the Effect of Dendritic Cell Vaccination in a Model of Murine Multiple Myeloma

   Thanh-Nhan Nguyen-Pham, Sung‐Hoon Jung, Manh-Cuong Vo +7

   Maqola20152 iqtibos

   ABIABI:AkademIndex/2026.other.296783

4. A phase I clinical study of autologous dendritic cell therapy in patients with relapsed or refractory multiple myeloma

   Sung‐Hoon Jung, Hyunju Lee, Youn-Kyung Lee +5

   Maqola20172 iqtibos

   ABIABI:AkademIndex/2026.other.296824

5. Immunotherapy for the treatment of multiple myeloma

   Sung‐Hoon Jung, Hyunju Lee, Manh-Cuong Vo +2

   Sharh maqola20172 iqtibos

   ABIABI:AkademIndex/2026.other.296825

6. Lenalidomide and Programmed Death-1 Blockade Synergistically Enhances the Effects of Dendritic Cell Vaccination in a Model of Murine Myeloma

   Manh-Cuong Vo, Sung‐Hoon Jung, Tan-Huy Chu +6

   Maqola20182 iqtibos

   ABIABI:AkademIndex/2026.other.296835

7. Synergistic Antimyeloma Activity of Dendritic Cells and Pomalidomide in a Murine Myeloma Model

   Manh-Cuong Vo, Seoyun Yang, Sung‐Hoon Jung +6

   Maqola20182 iqtibos

   ABIABI:AkademIndex/2026.other.296837

8. Cellular immunotherapy in multiple myeloma

   Manh-Cuong Vo, Thangaraj Jaya Lakshmi, Sung‐Hoon Jung +7

   Sharh maqola20192 iqtibos

   ABIABI:AkademIndex/2026.other.296845

9. Potent anti-myeloma efficacy of dendritic cell therapy in combination with pomalidomide and programmed death-ligand 1 blockade in a preclinical model of multiple myeloma

   Tan-Huy Chu, Manh-Cuong Vo, Hye-Seong Park +4

   Maqola20202 iqtibos

   ABIABI:AkademIndex/2026.other.296867

10. Expansion of cytotoxic natural killer cells in multiple myeloma patients using K562 cells expressing OX40 ligand and membrane-bound IL-18 and IL-21

    Jaya Lakshmi Thangaraj, Minh‐Trang Thi Phan, SoonHo Kweon +14

    Maqola20212 iqtibos

    ABIABI:AkademIndex/2026.other.296889

11. Novel IL-15 dendritic cells have a potent immunomodulatory effect in immunotherapy of multiple myeloma

    Tan-Huy Chu, Manh-Cuong Vo, Jaya Lakshmi Thangaraj +8

    Maqola20222 iqtibos

    ABIABI:AkademIndex/2026.other.296905

12. Expanded natural killer cells potentiate the antimyeloma activity of daratumumab, lenalidomide, and dexamethasone in a myeloma xenograft model

    Jaya Lakshmi Thangaraj, Sung‐Hoon Jung, Manh-Cuong Vo +11

    Maqola20222 iqtibos

    ABIABI:AkademIndex/2026.other.296917

13. Exploring cellular immunotherapy platforms in multiple myeloma

    Manh-Cuong Vo, Sunghoon Jung, Van‐Tan Nguyen +11

    MaqolaOAOchiq kirishCAR-T cell therapy researchHeliyon20241 iqtibos

    ABIABI:AkademIndex/2026.other.102962

14. Exploring Cellular Immunotherapy Platforms in Multiple Myeloma

    Manh-Cuong Vo, Sunghoon Jung, Van‐Tan Nguyen +11

    PreprintCAR-T cell therapy researchSSRN Electronic Journal20230 iqtibos

    ABIABI:AkademIndex/2023.preprint.000164